Page last updated: 2024-11-06

mitomycin and Pelvic Pain

mitomycin has been researched along with Pelvic Pain in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Pelvic Pain: Pain in the pelvic region of genital and non-genital origin.

Research Excerpts

ExcerptRelevanceReference
"Patients with unresectable recurrent rectal cancer that progresses after systemic chemotherapy and radiotherapy are candidates for palliation with hypoxic pelvic perfusion (HPP)."1.48Palliation with a multimodality treatment including hypoxic pelvic perfusion for unresectable recurrent rectal cancer: outcomes based on a retrospective study. ( Bencivenga, M; Clementi, M; Fiorentini, C; Guadagni, S; Kusamura, S; Masedu, F, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guadagni, S1
Clementi, M1
Bencivenga, M1
Kusamura, S1
Fiorentini, C1
Masedu, F1

Other Studies

1 other study available for mitomycin and Pelvic Pain

ArticleYear
Palliation with a multimodality treatment including hypoxic pelvic perfusion for unresectable recurrent rectal cancer: outcomes based on a retrospective study.
    Updates in surgery, 2018, Volume: 70, Issue:4

    Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Immunological; Cetuximab; Chemotherapy, Ca

2018